FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097769247> ?p ?o ?g. }

• W3097769247 abstract "Radioligand therapy is a type of internal radiotherapy combining a short-range radioisotope labelled to a carrier with high affinity for a specific receptor expressed on tumor cells. Targeted alpha therapy (TAT) combines a high-LET emitter (225Ac) with a prostate-specific membrane antigen (PSMA) carrier specifically binding tumor cells in patients with metastatic castration-resistant prostate cancer (mCRPC). Whilst the antitumor activity of 225Ac-PSMA is well documented, this treatment is nowadays only used as salvage therapy because the therapeutic window is limited by the high incidence of xerostomia. Thus methods to reduce salivary toxicity and models able to describe xerostomia incidence are needed. We recently studied the efficacy of salivary gland protectors administered in combination with 177Lu-PSMA therapy. Starting from these data, we performed a predictive dosimetric evaluation of 225Ac-PSMA to assess the impact of salivary gland protectors in TAT. 225Ac-PSMA predictive dosimetry was performed in 13 patients treated with 177Lu-PSMA. Sequential whole-body planar images were acquired 0.5-1 h, 16-24 h, 36-48 h and120 h post-injection. 177Lu time-activity curves were corrected for 225Ac physical decay and assumed in equilibrium for all daughters. The OLINDA/EXM spherical model was used for dose estimation of parotid and submandibular glands (PGs, SGs). Dose for each daughter was calculated and summed for the total dose estimation. The biologically effective dose formalism was extended to high-LET emitters (BEDH). For the total BEDH, including the contribution of all daughter isotopes, the brachytherapy formalism for a mixture of radionuclides was implemented. Equivalent doses in 2Gy/fraction (EQD2) were then calculated and compared with Normal Tissue Complication Probability (NTCP) model derived from External Beam Radiotherapy (EBRT) for grade≥2 xerostomia induction. Median predictive doses were 0.86 BdRBE5/MBq for PGs and 1.05 BdRBE5/MBq for SGs with 53% reduction compared to previously published data. The results show that the radiobiological model implemented is conservative as it overestimates the complication rate with respect the clinical data. Our data shows the possibility of reducing salivary gland uptake in TAT with the co-administration of organ protectors but these results should be confirmed for TAT with 225Ac-PSMA by carrying out prospective trials with defined toxicity endpoints and dosimetry procedures." @default.
• W3097769247 created "2020-11-09" @default.
• W3097769247 creator A5001267679 @default.
• W3097769247 creator A5024079131 @default.
• W3097769247 creator A5025560695 @default.
• W3097769247 creator A5025628907 @default.
• W3097769247 creator A5043991810 @default.
• W3097769247 creator A5044657023 @default.
• W3097769247 creator A5053431695 @default.
• W3097769247 creator A5057910692 @default.
• W3097769247 creator A5058812950 @default.
• W3097769247 creator A5061064559 @default.
• W3097769247 creator A5064728742 @default.
• W3097769247 creator A5083110122 @default.
• W3097769247 creator A5089554789 @default.
• W3097769247 date "2020-11-05" @default.
• W3097769247 modified "2023-10-15" @default.
• W3097769247 title "Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)" @default.
• W3097769247 cites W1529490909 @default.
• W3097769247 cites W1529678579 @default.
• W3097769247 cites W1946923111 @default.
• W3097769247 cites W1978240508 @default.
• W3097769247 cites W1987981762 @default.
• W3097769247 cites W2004006404 @default.
• W3097769247 cites W2005574374 @default.
• W3097769247 cites W2014087379 @default.
• W3097769247 cites W2014544986 @default.
• W3097769247 cites W2017764929 @default.
• W3097769247 cites W2018649196 @default.
• W3097769247 cites W2018895767 @default.
• W3097769247 cites W2019242610 @default.
• W3097769247 cites W2024347398 @default.
• W3097769247 cites W2029517266 @default.
• W3097769247 cites W2032045530 @default.
• W3097769247 cites W2038628001 @default.
• W3097769247 cites W2044972294 @default.
• W3097769247 cites W2062783003 @default.
• W3097769247 cites W2076668534 @default.
• W3097769247 cites W2084238451 @default.
• W3097769247 cites W2097910608 @default.
• W3097769247 cites W2106506685 @default.
• W3097769247 cites W2121397606 @default.
• W3097769247 cites W2129115713 @default.
• W3097769247 cites W2130334935 @default.
• W3097769247 cites W2133144211 @default.
• W3097769247 cites W2152649674 @default.
• W3097769247 cites W2166406736 @default.
• W3097769247 cites W2166550367 @default.
• W3097769247 cites W2178389534 @default.
• W3097769247 cites W2200903217 @default.
• W3097769247 cites W2224788014 @default.
• W3097769247 cites W2259239971 @default.
• W3097769247 cites W2278392405 @default.
• W3097769247 cites W2303817381 @default.
• W3097769247 cites W2304896218 @default.
• W3097769247 cites W2606187374 @default.
• W3097769247 cites W2626822213 @default.
• W3097769247 cites W2725251074 @default.
• W3097769247 cites W2743828160 @default.
• W3097769247 cites W2753764866 @default.
• W3097769247 cites W2782678772 @default.
• W3097769247 cites W2784080506 @default.
• W3097769247 cites W2799931007 @default.
• W3097769247 cites W2800152799 @default.
• W3097769247 cites W2809795864 @default.
• W3097769247 cites W2899125520 @default.
• W3097769247 cites W2900887235 @default.
• W3097769247 cites W2911299254 @default.
• W3097769247 cites W2967856517 @default.
• W3097769247 cites W2970267549 @default.
• W3097769247 cites W2981188799 @default.
• W3097769247 cites W3019056157 @default.
• W3097769247 cites W3027729807 @default.
• W3097769247 doi "https://doi.org/10.3389/fonc.2020.531660" @default.
• W3097769247 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7674768" @default.
• W3097769247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33251129" @default.
• W3097769247 hasPublicationYear "2020" @default.
• W3097769247 type Work @default.
• W3097769247 sameAs 3097769247 @default.
• W3097769247 citedByCount "12" @default.
• W3097769247 countsByYear W30977692472021 @default.
• W3097769247 countsByYear W30977692472022 @default.
• W3097769247 countsByYear W30977692472023 @default.
• W3097769247 crossrefType "journal-article" @default.
• W3097769247 hasAuthorship W3097769247A5001267679 @default.
• W3097769247 hasAuthorship W3097769247A5024079131 @default.
• W3097769247 hasAuthorship W3097769247A5025560695 @default.
• W3097769247 hasAuthorship W3097769247A5025628907 @default.
• W3097769247 hasAuthorship W3097769247A5043991810 @default.
• W3097769247 hasAuthorship W3097769247A5044657023 @default.
• W3097769247 hasAuthorship W3097769247A5053431695 @default.
• W3097769247 hasAuthorship W3097769247A5057910692 @default.
• W3097769247 hasAuthorship W3097769247A5058812950 @default.
• W3097769247 hasAuthorship W3097769247A5061064559 @default.
• W3097769247 hasAuthorship W3097769247A5064728742 @default.
• W3097769247 hasAuthorship W3097769247A5083110122 @default.
• W3097769247 hasAuthorship W3097769247A5089554789 @default.
• W3097769247 hasBestOaLocation W30977692471 @default.
• W3097769247 hasConcept C121608353 @default.
• W3097769247 hasConcept C126322002 @default.

• next